These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 7698050)

  • 1. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.
    Richard JL; Parer-Richard C; Daures JP; Clouet S; Vannereau D; Bringer J; Rodier M; Jacob C; Comte-Bardonnet M
    Diabetes Care; 1995 Jan; 18(1):64-9. PubMed ID: 7698050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer.
    UCHI H; IGARASHI A; URABE K; KOGA T; NAKAYAMA J; KAWAMORI R; TAMAKI K; HIRAKATA H; OHURA T; FURUE M
    Eur J Dermatol; 2009; 19(5):461-8. PubMed ID: 19638336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.
    Hanft JR; Pollak RA; Barbul A; van Gils C; Kwon PS; Gray SM; Lynch CJ; Semba CP; Breen TJ
    J Wound Care; 2008 Jan; 17(1):30-2, 34-7. PubMed ID: 18210954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: a randomized, controlled trial.
    Ma C; Hernandez MA; Kirkpatrick VE; Liang LJ; Nouvong AL; Gordon II
    Wounds; 2015 Apr; 27(4):83-91. PubMed ID: 25855851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
    Wieman TJ; Smiell JM; Su Y
    Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo.
    Steed DL; Goslen JB; Holloway GA; Malone JM; Bunt TJ; Webster MW
    Diabetes Care; 1992 Nov; 15(11):1598-604. PubMed ID: 1468291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial.
    Park KH; Han SH; Hong JP; Han SK; Lee DH; Kim BS; Ahn JH; Lee JW
    Diabetes Res Clin Pract; 2018 Aug; 142():335-344. PubMed ID: 29902542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial.
    Balingit PP; Armstrong DG; Reyzelman AM; Bolton L; Verco SJ; Rodgers KE; Nigh KA; diZerega GS
    Wound Repair Regen; 2012; 20(4):482-90. PubMed ID: 22672145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study Group.
    Steed DL; Ricotta JJ; Prendergast JJ; Kaplan RJ; Webster MW; McGill JB; Schwartz SL
    Diabetes Care; 1995 Jan; 18(1):39-46. PubMed ID: 7698046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
    Kalani M; Apelqvist J; Blombäck M; Brismar K; Eliasson B; Eriksson JW; Fagrell B; Hamsten A; Torffvit O; Jörneskog G
    Diabetes Care; 2003 Sep; 26(9):2575-80. PubMed ID: 12941721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial.
    Gomez-Villa R; Aguilar-Rebolledo F; Lozano-Platonoff A; Teran-Soto JM; Fabian-Victoriano MR; Kresch-Tronik NS; Garrido-Espíndola X; Garcia-Solis A; Bondani-Guasti A; Bierzwinsky-Sneider G; Contreras-Ruiz J
    Wound Repair Regen; 2014; 22(4):497-503. PubMed ID: 25041620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes.
    Tom WL; Peng DH; Allaei A; Hsu D; Hata TR
    Arch Dermatol; 2005 Nov; 141(11):1373-7. PubMed ID: 16301384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study.
    Lyons TE; Miller MS; Serena T; Sheehan P; Lavery L; Kirsner RS; Armstrong DG; Reese A; Yankee EW; Veves A
    Am J Surg; 2007 Jan; 193(1):49-54. PubMed ID: 17188087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical application of the bee hive protectant propolis is well tolerated and improves human diabetic foot ulcer healing in a prospective feasibility study.
    Henshaw FR; Bolton T; Nube V; Hood A; Veldhoen D; Pfrunder L; McKew GL; Macleod C; McLennan SV; Twigg SM
    J Diabetes Complications; 2014; 28(6):850-7. PubMed ID: 25239451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human epidermal growth factor enhances healing of diabetic foot ulcers.
    Tsang MW; Wong WK; Hung CS; Lai KM; Tang W; Cheung EY; Kam G; Leung L; Chan CW; Chu CM; Lam EK
    Diabetes Care; 2003 Jun; 26(6):1856-61. PubMed ID: 12766123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of basic fibroblast growth factor on the healing of cutaneous chronic wounds].
    Fu XB; Guo ZR; Sheng ZY
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1999 Sep; 13(5):270-2. PubMed ID: 12080816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial.
    Squadrito F; Bitto A; Altavilla D; Arcoraci V; De Caridi G; De Feo ME; Corrao S; Pallio G; Sterrantino C; Minutoli L; Saitta A; Vaccaro M; Cucinotta D
    J Clin Endocrinol Metab; 2014 May; 99(5):E746-53. PubMed ID: 24483158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
    Buzzi M; de Freitas F; Winter M
    Ostomy Wound Manage; 2016 Mar; 62(3):8-24. PubMed ID: 26978856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers.
    Martínez-de Jesús FR; Morales-Guzmán M; Castañeda M; Pérez-Morales A; García-Alonso J; Mendiola-Segura I
    Arch Med Res; 1997; 28(1):95-9. PubMed ID: 9078595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.